The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Transaction #26708 · Form 4 · 0001213900-26-000661

ORAMED PHARMACEUTICALS INC. · Stock award · Common Stock

ORAMED PHARMACEUTICALS INC. · Transacted December 31, 2025 · Filed January 2, 2026

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for ORAMED PHARMACEUTICALS INC. records a stock award involving Common Stock on December 31, 2025. The reported quantity was 30,000. The filing date is January 2, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001176309
Security type
Non-derivative
Acquisition type
Stock award · Code A
Quantity acquired
30,000
Reported price
Not reported · See footnotes
Reference value
Not reported
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
107,191
Ownership description
Not reported
SEC acceptance time
Jan 2, 2026, 8:02 PM EST
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

ORMP · Nasdaq · linked security

The linked listing is identified separately from other current company listings.

Filing footnotes & remarks

F1
Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.
F2
Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.